Complications from the use of punctum plugs to treat aqueous insufficiency are fairly uncommon; however, adverse events can be minimized by selecting the appropriate patient and choosing specific plug ...
Please provide your email address to receive an email when new articles are posted on . Punctal plugs are criticized by some due to their possible connection to granulomas and dacryocystitis. For this ...
Two-month sustained release drug may improve therapy over topical drop administration. BEDFORD, Mass., Aug. 21, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost ...
This punctal plug prototype both blocks tear drainage and delivers dry-eye medication. Image courtesy of UNIVERSITY OF FLORIDA “It is estimated that 10–30% of people suffer from the condition known as ...
VANCOUVER, July 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced encouraging interim data from an ongoing Phase ...
The first tear duct implant developed to treat inflammation and pain following cataract surgery has been shown to be a reliable alternative to medicated eye drops, which are the current standard of ...
A retrospective administrative claims analysis of treatment options for dry eye disease (DED) evaluated treatment patterns and utilization characteristics of patients receiving cyclosporine, punctal ...
Completion of Facility Enables Initiation of Phase 3 Clinical Trial of Nepafenac in Patients Undergoing Cataract Surgery AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") ...
Up to twenty patients will be enrolled at Singapore National Eye Center and the National University Hospital in Singapore. Patients with documented ocular hypertension or open-angle glaucoma are ...
BEDFORD, Mass., Aug. 20, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical ...
Two-month sustained release drug may improve therapy over topical drop administration. BEDFORD, Mass., Aug. 20, 2012 -- Following encouraging results from Ocular Therapeutix's travoprost punctum plug ...